Indications |
Oral Meniere's disease Adult: Initially, 16 mg tid. Maintenance: 24-48 mg daily. |
Contraindications |
Phaeochromocytoma. Porphyria. |
Warnings / Precautions |
Active peptic ulcer, bronchial asthma, pregnancy and lactation. |
Adverse Reactions |
Rash, pruritus, urticaria, dyspepsia, nausea, peptic ulcer disease, headache, dizziness, insomnia. |
Drug Interactions |
May antagonise antihistamines. May decrease bronchodilator effects of β-2 agonists. See Below for More betahistine Drug Interactions |
Mechanism of Actions |
Betahistine improves the microcirculation in the labyrinth which reduces endolymphatic pressure. Absorption: Rapid and complete. Metabolism: Hepatic. Excretion: Urine (as inactive metabolites); 3.4 hr (elimination half-life). |
Administration |
Should be taken with food. |
Storage Conditions |
Oral: Store below 25°C. |
ATC Classification |
N07CA01 - betahistine ; Belongs to the class of antivertigo preparations. |
Storage |
Oral: Store below 25°C. |
Available As |
|
Betahistine
Post Review about Betahistine Click here to cancel reply.
Betahistine Containing Brands
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.